Company Filing History:
Years Active: 2007
Title: Brian Collingwood Clark: Innovator in Peptide Release Formulations
Introduction
Brian Collingwood Clark is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of peptide release mechanisms. His innovative approach has the potential to enhance quality control processes in drug development.
Latest Patents
Clark holds a patent for a method titled "Method for determining release of a peptide from a sustained release polylactide formulation." This method allows for the determination of peptide release in a shorter time frame compared to traditional real-time methods. By accelerating the release of the peptide from the formulation, this technique can effectively discriminate between different batches for quality control purposes, as well as differentiate formulations with varying drug loadings.
Career Highlights
Brian Clark is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on advancing drug delivery systems and improving therapeutic outcomes through innovative formulation strategies.
Collaborations
Clark has collaborated with esteemed colleagues, including David Michael Cross and Paul Richard Gellert. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge pharmaceutical solutions.
Conclusion
Brian Collingwood Clark's contributions to peptide release formulations exemplify the importance of innovation in the pharmaceutical industry. His work not only advances scientific understanding but also improves the quality and efficacy of drug formulations.